Study Summary
This trial is testing a new treatment for a low-risk type of skin cancer.
- Basal Cell Carcinoma
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: Approximately 119 days
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
4 Treatment Groups
AIV001 Treatment Dose 3
1 of 4
AIV001 Treatment Dose 4
1 of 4
AIV001 Treatment Dose 2
1 of 4
AIV001 Treatment Dose 1
1 of 4
Experimental Treatment
26 Total Participants · 4 Treatment Groups
Primary Treatment: AIV001 · No Placebo Group · Phase 1 & 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 80 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is there still capacity for people to join this research trial?
"Affirmative. Evidence on clinicaltrials.gov implies that this research is actively recruiting volunteers, with the original posting being made on August 18th 2020 and most recently updated July 19th 2022. The medical trial requires 24 participants to be obtained from one centre." - Anonymous Online Contributor
Is this trial open to elderly participants aged 85 and over?
"This medical trial is open to individuals aged 18 and over, but not exceeding 80 years." - Anonymous Online Contributor
Am I qualified to take part in this trial?
"This medical trial seeks 24 participants with carcinoma between the ages of 18 and 80. Prospective applicants must meet these conditions to be eligible for the study." - Anonymous Online Contributor
What is the aggregate number of participants in this trial?
"Yes, according to clinicaltrials.gov this trial is presently accepting enrollees. It was first promoted on August 18th 2020 and the most recent change was made July 19th 2022. The research team needs 24 participants from a single medical facility for their investigation." - Anonymous Online Contributor